Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem - A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data | Citedby Results | Public Health Genomics

Skip Nav Destination

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem - A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data

Public Health Genomics (2016) 19 (4): 211–219.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Integrated but Isolated: Implications from a Systematic Review of the Access Control Ecosystem for Individual Participant Data in Clinical Studies

Jian‐Sin Lee
Wei Jeng

Proceedings of the Association for Information Science and Technology (2022) 59 (1): 447.

Global Open Health Data Cooperatives Cloud in an Era of COVID-19 and Planetary Health

Ankit Singh Tanwar
Nikolaos Evangelatos
Julien Venne
Lesley Ann Ogilvie
Kapaettu Satyamoorthy
Angela Brand

OMICS: A Journal of Integrative Biology (2021) 25 (3): 169.

Big Data Applications the Banking Sector: A Bibliometric Analysis Approach

Haitham Nobanee
Mehroz Nida Dilshad
Mona Al Dhanhani
Maitha Al Neyadi
Sultan Al Qubaisi
Saeed Al Shamsi

Sage Open (2021) 11 (4)

Digital Transformation and Governance Innovation for Public Biobanks and Free/Libre Open Source Software Using a Blockchain Technology

Nikolaos Evangelatos
Sudhakara P. Upadya
Julien Venne
Kapaettu Satyamoorthy
Helmut Brand
C.S. Ramashesha
Angela Brand

OMICS: A Journal of Integrative Biology (2020) 24 (5): 278.

Values, challenges and future directions of big data analytics in healthcare: A systematic review

P. Galetsi
K. Katsaliaki
S. Kumar

Social Science & Medicine (2019) 241: 112533.

Wie verbessern Wissensmanagement und Open Data die Arzneimittelentwicklung und ‑zulassung?

Rukiye Gül

Information - Wissenschaft & Praxis (2018) 69 (5-6): 276.

Use of Free/Libre Open Source Software in Sepsis “-Omics” Research: A Bibliometric, Comparative Analysis Among the United States, EU-28 Member States, and China

Nikolaos Evangelatos
Kapaettu Satyamourthy
Georgia Levidou
Helmut Brand
Pia Bauer
Christina Kouskouti
Angela Brand

OMICS: A Journal of Integrative Biology (2018) 22 (5): 365.

Multi-Omics Research Trends in Sepsis: A Bibliometric, Comparative Analysis Between the United States, the European Union 28 Member States, and China

Nikolaos Evangelatos
Kapaettu Satyamoorthy
Georgia Levidou
Pia Bauer
Helmut Brand
Christina Kouskouti
Hans Lehrach
Angela Brand

OMICS: A Journal of Integrative Biology (2018) 22 (3): 190.

The 13th Round: Article 39(3) TRIPS and the struggle over “Unfair Commercial Use”

Gabriele Spina Alì

The Journal of World Intellectual Property (2018) 21 (3-4): 201.

Metabolomics in Sepsis and Its Impact on Public Health

Nikolaos Evangelatos
Pia Bauer
Matthias Reumann
Kapaettu Satyamoorthy
Hans Lehrach
Angela Brand

Public Health Genomics (2017) 20 (5): 274.

TRIPS and disclosure of clinical information: An intellectual property perspective on data sharing

Gabriele Spina Alì

The Journal of World Intellectual Property (2017) 20 (1-2): 24.

Challenges for Small Biopharmaceutical Companies

New England Journal of Medicine (2017) 376 (17): 1697.

‘Omics Approaches in Breast Cancer Research and Clinical Practice

Priyakshi Kalita-de Croft
Fares Al-Ejeh
Amy E. McCart Reed
Jodi M. Saunus
Sunil R. Lakhani

Advances in Anatomic Pathology (2016) 23 (6): 356.

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem - A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data

INFORMATION

ABOUT US

SERVICES FOR

Karger International

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem - A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data

This Feature Is Available To Subscribers Only